Marco Agostini is currently appointed as a Research Scientist and Assistant Professorat the 1st Clinical Surgery, Dep. Surgical Sciences Oncological and Gastroentero logical Sciences, University of Padova, Padova, Italy.

He is Senior Affiliate Member of The Department of Nanomedicine,
The Methodist Hospital ResearchInstitute, Houston, TX and Nano Inspired Biomedicine, Istituto di Ricerca Pediatrica (IRP)- Fondazione Città della Speranza, Padova, IT.

His research focuses on the study of genetic and molecularcharacterization of cancer with a concentration on the genetic pathway involved in the progression and outcome of colon cancer as well as drug delivery system modulation. In collaboration with researchers at The Methodist Hospital Research Institute, he is developing nanotechnology applications to enhance proteomic profiling for cancer research. His aims are to improve cancer detection by identifying specific cancer biomarkers and the timing of their interrelated functional molecular contributions to cancer progression.